Application of External Microwave Thermotherapy in Urology: Past, Present, and Future

Journal of Endourology

Volumn 17, Issue 8, 2003, Pages 659-666

  Gravas, Stavros ^a   Laguna, M Pilar ^a   De La Rosette, Jean J M C H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; CELL KILLING; ECONOMICS; FEMALE; HEALTH CARE COST; HEAT; HUMAN; HYPERTHERMIC THERAPY; MALE; METHODOLOGY; MICROWAVE RADIATION; MORBIDITY; PATIENT SELECTION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RADIATION EXPOSURE; RESEARCH; REVIEW; TEMPERATURE DEPENDENCE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TREATMENT PLANNING; URODYNAMICS; UROGENITAL TRACT TUMOR; UROLOGY;

EID: 0242330282     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/089277903322518671     Document Type: Review

References (64)

1. Laguna MP, Muschter R, Debruyne FMJ. Microwave thermotherapy: Historical overview. J Endourol 2000;14:603-610.
2. Brehmer M, Baba S. Transurethral microwave thermotherapy: How does it work? J Endourol 2000;14:611-615.
3. Brehmer M. Morphological changes in prostatic adenomas after transurethral microwave thermotherapy. Br J Urol 1997;80: 123-127.
4. Brehmer M, Svensson I. Heat-induced apoptosis in human prostatic stromal cells. BJU Int 2000;85:535-541.
5. Brehmer M, Hilliges M, Kinn AC. Denervation of periurethral prostatic tissue by transurethral microwave thermotherapy. Scand J Urol Nephrol 2000;34:42-45.
6. Brehmer M, Nilsson BY. Elevation of sensory thresholds in the prostatic urethra after microwave thermotherapy. BJU Int 2000; 86:427-431.
7. Bolmsjo M, Wagrell L, Hallin A, et al. The heat is on-But how? A comparison of TUMT devices. Br J Urol 1996;78:564-572.
8. Djavan B, Larson TR, Blute ML, Marberger M. Transurethral microwave thermotherapy: What role should it play versus medical management in the treatment of benign prostatic hyperplasia? Urology 1998;52:935-947.
9. d'Ancona FCH, Francisca EAE, Witjes WP, et al. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: Long-term results. Br J Urol 1998;81:259-264.
10. Ahmed M, Bell T, Lawrence WT, et al. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: A randomized, controlled, parallel study. Br J Urol 1997;79:181-185.
11. Floratos DL, Kiemeney LA, Rossi C, et al. Long-term follow-up of a randomized TUMT versus TURP study. J Urol 2001;165: 1533-1538.
12. Wagrell L, Schelin S, Nordling J, et al. Feedback microwave thermotherapy versus TURP for clinical BPH: A randomized controlled multicenter study. Urology 2002;60:292-299.
13. Hofner K, Gonnermann O, Grunewald V, et al. Urodynamics and transurethral microwave thermotherapy. World J Urol 1998;16: 131-137.
14. Thalmann GN, Mattei A, Treuthardt C, et al. Transurethral microwave thermotherapy in 200 patients with a minimum followup of 2 years: Urodynamic and clinical results. J Urol 2002;167: 2496-2501.
15. Osman Y, Wadie B, El-Diasty T, Larson T. High-energy transurethral microwave thermptherapy: Symptomatic vs urodynamic success. BJU Int 2003;91:365-370.
16. Keijers CBJM, Francisca EAE, D'Ancona FCH, et al. Long-term results of lower energy TUMT. J Urol 1998;159:1966-1973.
17. Tsai YS, Lin JSN, Tong YC, et al. Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: Long term durability with Prostcare. Eur Urol 2001;39:688-694.
18. Terada N, Aoki Y, Ichioka K, et al: Microwave thermotherapy for benign prostatic hyperplasia with the Domier Urowave: Response durability and variables potentially predicting response. Urology 2001;57:701-706.
19. Ekstrand V, Westermark S, Wiksell H, et al. Long-term clinical outcome of transurethral microwave thermotherapy (TUMT) 1991-1999 at Karolinska Hospital, Sweden. Scand J Urol Nephrol 2002;36:113-118.
20. Francisca EAE, Keijers GB, Floratos DL, et al. High energy transurethral microwave thermotherapy: Long-term follow up results. (in press)
21. Tubaro A, d'Ancona FCH. Case selection for high-energy transurethral microwave thermotherapy. World J Urol 1998;16: 124-130.
22. d'Ancona FCH, Francisca EAE, Debruyne FMJ, de la Rosette JJMCH. High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms. J Endourol 1997;11: 285-289.
23. d'Ancona FCH, Fransisca EAE, Hendriks JCM, et al. The predictive value of baseline parameters in the treatment of benign prostatic hyperplasia using high energy transurethral microwave thermotherapy. Br J Urol 1998;82:808-813.
24. Gravas S, Laguna MP, de la Rosette JJMCH. Efficacy and safety of intraprostatic temperature controlled microwave thermotherapy in pafients with benign prostatic hyperplasia: Results of a prospective, open label, single center study with 1-year follow-up. J Endourol (in press).
25. Floratos DL, de la Rosette JJMCH. Heat treatment of the prostate: Where do we stand in 2000? Curr Opin Urol 2001;11:35-41.
26. d'Ancona, Albers YH, Kiemeney LA, et al. Can histopathology predict treatment outcome following high energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study. Prostate 1999;40:28-36.
27. Floratos DL, Sedelaar JPM, Kortmann BBM, et al. Intra-prostatic vasculature studies: Can they predict the outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction? Prostate 2001;46:200-206.
28. Djavan B, Bursa B, Basharkhah A, et al. Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy. Urology 2000;55:51-57.
29. Laguna MP, Kiemeney LA, Debruyne FJ, de la Rosette JJMCH. Baseline prostate-specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 2002;167:1727-1730.
30. Djavan B, Shariat S, Schafer B, Marberger M. Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: Results of a prospective, randomized, single-blinded clinical trial. J Urol 1998;160:772-776.
31. Dahlstrand C, Walden M, Geirsson G, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: A prospective randomized study with a 2-year follow-up. Br J Urol 1995;76:614-618.
32. d'Ancona FCH, Francisca EAE, Witjes WPJ, et al. High energy thermotherapy (TUMT) versus transurethral resection (TURP) in the treatment of benign prostatic hyperplasia (BPH): Results of a prospective randomized study with a 1-year follow-up. J Urol 1997;158:120-125.
33. Francisca EAE, d'Ancona FCH, Meuleman EJH, et al. Sexual function following high energy microwave thermotherapy: Results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999; 161:486-490.
34. d'Ancona FCH, van der Bij AK, Francisca EAE, et al. The results of high energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthiologists operative risk classification (ASA). Urology 1999;54:18-22.
35. Eliasson T, Damber JE. Temperature controlled high energy transurethral microwave thermotherapy for benign prostatic hyperplasia using a heat shock strategy. J Urol 1998;160:777-781.
36. Carter S, Tubaro A. Relation between intraprostatic temperature and clinical outcome in microwave thermotherapy. J Endourol 2000;14:617-625.
37. Larson TR, Collins JM, Corica A. Detailed interstitial temperature mapping during treatment with a novel transurethral microwave thermoablation system in patients with benign prostatic hyperplasia. J Urol 1998;159:258-264.
38. Mauroy B, Chive M, Stefaniak X, et al. Study on the effects of thermotherapy in benign prostatic hyperplasia. Eur Urol 1997; 32:198.
39. Chen JC, Moriarty JA, Derbyshire JA, et al. Prostate cancer: MR imaging and thermometry during microwave thermal ablation: Initial experience. Radiology 2000;214:290-297.
40. Simon C, van Baren P, Ebbini ES. Two-dimensional temperature estimation using diagnostic ultrasound. IEEE Trans Ultrason Ferroelectr Freq Contr 1998;45:1088.
41. Wagrell L, Schelin S, Bolmsjo M, Brudin L. Intraprostatic temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia. J Urol 1998; 159:1583-1587.
42. Bolmsjo M, Schelin S, Wagrell L, et al. Cell-kill modeling of microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol 2000;14:627-635.
43. Hoffmann AL, Laguna MP, de la Rosette JJMCH, Wijkstra H. Quantification of prostate shrinkage after microwave thermotherapy: A comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur Urol 2003;43:181-187.
44. Nordling J, Schelin S, Mattiasson A, et al. Intraprostatic temperature measurement during microwave treatment provides online control of tissue necrosis volume using ProstaLund microwave feedback treatment [abstract]. J Endourol 2001;15(suppl):A89.
45. Bolmsjø M, Sturesson C, Wagrell L, et al. Optimizing transurethral microwave thermotherapy a model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol 1998; 81:811-816.
46. Bhowmick P, Coad JE, Bhowmick S, et al. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int J Hyperthermia (in press).
47. Floratos DL, Sonke GS, Francisca EAE, et al. Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 2000;56:604-609.
48. Manyak MJ, Ackerman SJ, Blute ML, et al. Cost effectiveness of treatment for benign prostatic hyperplasia: An economic model for comparison of medical, minimally invasive, and surgical therapy. J Endourol 2002;16:51-56.
49. Stoevelaar HJ, McDonnel J. Changing therapeutic regimens in benign prostatic hyperplasia: Clinical and economic considerations. Pharmacoeconomics 2001;19:131-153.
50. Baltussen RMPM, Wielink G, Stoevelaar HJ, et al. The economic impact of introducing transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia: A scenario analysis. World J Urol 1998;16:142-147.
51. Floratos DL, Severens JL, Kiemeney LA, et al. Transurethral resection versus microwave thermotherapy of the prostate: A cost-consequences analysis. BJU Int (submitted)
52. Rosette JJMCH de la, Alivizatos G, Madersbacher S, Perachino M, Thomas D, Desgrandchamps F, de Wildt M. EAU Guidelines on Benign Prostatic Hyperplasia (BPH). Eur Urol 2000;40:256-263.
53. Rosette JJMCH de la, Gravas S, Muschter R, Rassweiler J, Joyce A, Members of the Board of the ESUT. Present practice and development of minimally invasive techniques, imaging and training in European urology: Results of a survey of the European Society of Uro-Technology (ESUT). Eur Urol (in press).
54. Tabuse K. [A new operative procedure of hepatic surgery using a microwave tissue coagulator] (Jpn). Nippon Geka Hokan 1979; 48:160-172.
55. Naito S, Nakashima M, Kimoto Y, et al. Application of microwave tissue coagulator in partial nephrectomy for renal cell carcinoma. J Urol 1998;159:960-962.
56. Muraki J, Cord J, Addonizio JC, et al. Application of microwave tissue coagulation in partial nephrectomy. Urology 1991;37: 282-287.
57. Yoshimura K, Okubo Ichioka K, et al. Laparoscopic partial nephrectomy with a microwave tissue coagulator for small renal tumors. J Urol 2001;165:1893-1896.
58. Colombo R, da Pozzo LF, Lev A, et al. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. J Urol 1998;159:783-787.
59. Mauroy B, Bonnal JL, Prevost B, et al. Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder. Prog Urol 1999;9:69-80.
60. Dietsch A, Camart JC, Sozanski JP, et al. Microwave thermochemotherapy in the treatment of the bladder carcinoma-Electromagnetic and dielectric studies-Clinical protocol. IEEE Trans Biomed Eng 2000;47:633-641.
61. Bostwick DG, Larson TR. Transurethral microwave thermal therapy: Pathologic findings in the canine prostate. Prostate 1995;26: 116-122.
62. Montorsi F, Guazzoni G, Colombo R, et al. Transrectal microwave hyperthermia for advanced prostate cancer: long-term clinical results. J Urol 1992;148:342-345.
63. Anscher MS, Samulski TV, Dodge R, et al. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997;37:1059-1065.
64. Khair AA, Pacelli A, Iczkowski KA, et al. Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue? Urology 1999;54:67-72.